The Vector W8 arrived as if it had slipped through a wormhole from a stranger, faster future, a low, angular projectile that ...

AI is changing search, but traditional SEO still drives most traffic. Real-world data shows which tactics continue to perform ...

This year’s best and most-read stories range from investigative pieces to unforgettable personal narratives. These are the ...

Here's a helmet at the more budget end of the market that I have been using for night time riding recently - it has a number of unique features and twists up its sleeve....but is it any good? Stay ...

Satyen K. Bordoloi My first memory of cancer is the younger brother of a classmate. Blood cancer, we whispered between ...

An 'automated attacker' mimics the actions of human hackers to test the browser's defenses against prompt injection attacks. But there's a catch.

X-linked retinoschisis gene replacement therapy, aiming to improve retinal architecture and visual function in young male ...

Modalis Therapeutics Corporation (TOKYO: 4883) today announced that its research article titled "Efficient LAMA1 gene activation by epigenome editing as a therapeutic approach for LAMA2-CMD" has been ...

Nonprofit founder and CEO, Craig Martin, notes that the industry will likely see more alternative gene therapy commercialisation models in the future.

We recently compiled a list of the 7 Most Promising Gene Editing Stocks According to Analysts. BioMarin Pharmaceuticals Inc.

Sean Ryder, professor at UMass Chan Medical School, has written a book to delve the mysteries of ribonucleic acid as a tool to fight diseases. Messenger ribonucleic acid, or mRNA, is in the public ...

In a CiOL interaction, Superteams.ai Founder Soum Paul breaks down enterprise AI adoption, fractional AI teams, governance ...